Skip to content

Hypertensive treatment in older adults with vascular brain lesions: should we SPRINT faster?

Hypertensive treatment in older adults with cerebral small vessel disease: should we SPRINT faster?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24551
Enrollment
20
Registered
2017-08-28
Start date
2017-09-30
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Cerebral Small Vessel Disease (CSVD) Hypertensie Cerebrale wittestofschade

Interventions

intensive control (SBP &#8804
120 mmHg)

Sponsors

VU University Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • ≥ 65 years of age • High systolic blood pressure of 150-200mmHg based on the average of a daytime 24-hour BP (with or without taking antihypertensive medication) • Cerebral small vessel disease (white matter lesions; Fazekas score ≥ 2) on MRI

Exclusion criteria

Exclusion criteria: • Medical history of diabetes mellitus • Experienced myocardial infarction within the past 12 months • Medical history of stroke in the past 6 months or large (sub) cortical cerebral infarction on MRI • Medical history of end stage heart failure (NYHA III-IV) • Stage 4-5 kidney failure • Diagnosed with dementia • Life expectancy less than 1 year • Unable to obtain an optimal window for TCD measurements during first visit at the outward patient clinic • Significant stenosis (>70%) of the left of right common carotid artery

Design outcomes

Primary

MeasureTime frame
cerebral blood flow velocity

Secondary

MeasureTime frame
cognitive functioning, white matter lesions, orthostatic hypotension, dynamic cerebral autoregulatory capacity, CO2 responsiveness, experienced side effects, disability to reach assigned BP target

Contacts

Public ContactEmma Kleipool

Dept. Internal Medicine/Geriatrics, ZH 4A74

e.kleipool@vumc.nl020 444 2758

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)